Combined arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia recurring from previous relapses successfully treated using arsenic trioxide.

Combined arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia recurring from previous relapses successfully treated using arsenic trioxide.

Item
http://www.wikidata.org/entity/Q43936451
A review of arsenic trioxide and acute promyelocytic leukemiaL-type calcium current (ICa,L) and inward rectifier potassium current (IK1) are involved in QT prolongation induced by arsenic trioxide in rat.ATO/ATRA/anthracycline-chemotherapy sequential consolidation achieves long-term efficacy in primary acute promyelocytic leukemia.All-trans retinoic acid/As2O3 combination yields a high quality remission and survival in newly diagnosed acute promyelocytic leukemiaArsenic trioxide: safety issues and their management.Top five medical innovations in China mainland since Xinhai revolution [1911]: results of AME survey-002.Arsenic trioxide: an anti cancer missile with multiple warheads.Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia.Synergy against PML-RARa: targeting transcription, proteolysis, differentiation, and self-renewal in acute promyelocytic leukemia.Impact of arsenic trioxide in the treatment of acute promyelocytic leukemia.Pathogenesis and treatment of leukemia: an Asian perspective.Feasibility of oral arsenic trioxide treatment for acute promyelocytic leukemia during hemodialysis.Thyroid arsenic content and papillary thyroid carcinoma arising 10 years after oral arsenic trioxide therapy for refractory acute promyelocytic leukemia.Retinoid/arsenic combination therapy of promyelocytic leukemia: induction of telomerase-dependent cell death.FLT-3 aberrations in acute promyelocytic leukaemia: clinicopathological associations and prognostic impact.Outcomes and prognostic factors of first relapsed acute promyelocytic leukemia patients undergoing salvage therapy with intravenous arsenic trioxide and chemotherapy.
P2860

Combined arsenic trioxide and all-trans retinoic acid treatment for acute promyelocytic leukaemia recurring from previous relapses successfully treated using arsenic trioxide.

Item
http://www.wikidata.org/entity/Q43936451
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年学术文章
@wuu
2002年学术文章
@zh
2002年学术文章
@zh-cn
2002年学术文章
@zh-hans
2002年学术文章
@zh-my
2002年学术文章
@zh-sg
2002年學術文章
@yue
2002年學術文章
@zh-hant
name
Combined arsenic trioxide and ...... reated using arsenic trioxide.
@en
Combined arsenic trioxide and ...... reated using arsenic trioxide.
@nl
type
label
Combined arsenic trioxide and ...... reated using arsenic trioxide.
@en
Combined arsenic trioxide and ...... reated using arsenic trioxide.
@nl
prefLabel
Combined arsenic trioxide and ...... reated using arsenic trioxide.
@en
Combined arsenic trioxide and ...... reated using arsenic trioxide.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P50
P577
P5875
P698
P921
P356
P1433
P1476
Combined arsenic trioxide and ...... treated using arsenic trioxide
@en
P2093
P2860
P304
P31
P356
10.1046/J.1365-2141.2002.03409.X
P407
P433
P478
P50
P577
P5875
P698
P921